Modulation of the cellular and humoral immune response to pediatric open heart surgery by methylprednisolone

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 4, 2011, Pages 212-220

  Bocsi, Jozsef ^a   Hänzka, Marie Christin ^a   Osmancik, Pavel ^b   Hambsch, Jörg ^a   Dähnert, Ingo ^a   Sack, Ulrich ^a   Bellinghausen, Wilfried ^a   Schneider, Peter ^a   Janoušek, Jan ^a   Kostelka, Martin ^a   Tárnok, Attila ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

cardiopulmonary bypass; congenital heart defects; immune response; methylprednisolone; pediatric cardiac surgery

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE;

ANESTHESIA; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INVASION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HOSPITAL DISCHARGE; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NEUTROPHIL COUNT; OPEN HEART SURGERY; OUTPATIENT CARE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; POSTOPERATIVE PERIOD;

EID: 79954503590     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20587     Document Type: Conference Paper

References (58)

1. Casey LC,. Role of cytokines in the pathogenesis of cardiopulmonary- induced multisystem organ failure. Ann Thorac Surg 1993; 56: S93-S96.
2. Seghaye M-Ch, Duchateau J, Grabitz R-G, Faymonville ML, Messmer BJ, Buro-Rathsmann K, von Bernuth G,. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978-987.
3. Zhang S, Wang S, Li Q, Yao S, Zeng B, Ziegelstein RC, Hu Q,. Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: A double-blind, randomised controlled study. Lancet 2005; 366: 556-562. (Pubitemid 41140330)
4. Proulx F, Joyal JS, Mariscalco MM, Leteurtre S, Leclerc F, Lacroix J,. The pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med 2009; 10: 12-22.
5. Seghaye M-Ch, Duchateau J, Grabitz R-G, Wolff T, Marcus C, Engelhardt W, Hörnchen H, Messmer BJ, von Bernuth G,. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: A clinical and experimental study. J Thorac Cardiovasc Surg 1996; 111: 882-892. (Pubitemid 26118870)
6. Podbregar M, Mozina H,. Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock. Crit Care 2007; 11: R6.
7. Shakar S, Lowes BD,. Myocardial protection in sepsis. Crit Care 2008; 12: 177.
8. Vincent JL,. Understanding cardiac output. Crit Care 2008; 12: 174.
9. Wan S, LeClerc JL, Vincent JL,. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-692. (Pubitemid 27410703)
10. Hill GE,. Cardiopulmonary bypass-induced inflammation: Is it important? J Cardiothorac Vasc Anesth 1998; 12: 21-25. (Pubitemid 28185981)
11. Elliott M,. Modified ultrafiltration and open heart surgery in children. Paediatr Anaesth 1999; 9: 1-5. (Pubitemid 29065898)
12. Raja SG, Dreyfus GD,. Will off-pump coronary artery surgery replace conventional coronary artery surgery? J R Soc Med 2004; 97: 275-278. (Pubitemid 38797698)
13. Liberman AC, Druker J, Garcia FA, Holsboer F, Arzt E,. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann N Y Acad Sci 2009; 1153: 6-13.
14. Chaney MA,. Corticosteroids and cardiopulmonary bypass: A review of clinical investigations. Chest 2002; 121: 921-931. (Pubitemid 34251460)
15. Checchia PA, Bronicki RA, Costello JM, Nelson DP,. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers. Pediatr Crit Care Med 2005; 6: 441-444. (Pubitemid 40980824)
16. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF,. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107: 776-784. (Pubitemid 351325970)
17. Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, Teoh KH,. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials. Eur Heart J 2008; 29: 2592-2600.
18. Dickerson HA, Chang AC,. Steroids and low cardiac output syndrome after cardiac surgery in children. Pediatr Crit Care Med 2005; 6: 495-496. (Pubitemid 40980840)
19. Tárnok A, Pierzchalski A, Valet G,. Potential of a cytomics top-down strategy for drug discovery. Curr Med Chem 2010; 17: 1719-1729.
20. Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R, Kubicek M, Lottspeich F, Maser E, Mewes HW, Meyer HE, Müllner S, Mutter W, Neumaier M, Nollau P, Nothwang HG, Ponten F, Radbruch A, Reinert K, Rothe G, Stockinger H, Tárnok A, Taussig MJ, Thiel A, Thiery J, Ueffing M, Valet G, Vandekerckhove J, Wagener C, Wagner O, Schmitz G,. Approaching clinical proteomics: Current state and future fields of application in cellular proteomics. Cytometry A 2009; 75A: 816-832.
21. Hambsch J, Osmancik P, Bocsi J, Schneider P, Tárnok A,. Neutrophil adhesion molecule expression and serum concentration of soluble adhesion molecules during and after pediatric cardiovascular surgery with or without cardiopulmonary bypass. Anesthesiology 2002; 96: 1078-1085. (Pubitemid 34464120)
22. Lenz D, Hambsch J, Schneider P, Häusler HJ, Sauer U, Hess J, Tárnok A,. Protein-losing enteropathy in patients with Fontan circulation: Is it triggered by infection? Crit Care 2003; 7: 185-190. (Pubitemid 36432678)
23. Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tárnok A,. Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care 2002; 6: 226-233. (Pubitemid 34679181)
24. Bocsi J, Lenz D, Sauer U, Wild L, Hess J, Schneider P, Hambsch J, Schranz D, Tárnok A,. Inflammation and immune suppression following protein losing enteropathy after Fontan surgery detected by cytomics. Transfus Med Hemother 2007; 34: 168-175. (Pubitemid 46883381)
25. Mc Naught AD, Wilkinson A, editors. Compendium of chemical terminology. "The gold book," 2nd ed. Oxford: Blackwell Science; 1997 (ISBN 0-86542-684-8).
26. Birkett DJ,. Pharmacokinetics made easy, 2nd ed. Sydney, Australia: McGraw-Hill; 2002 (ISBN 0-07-471072-1079).
27. Laffers W, Schlenkhoff C, Kristina Pieper K, Mittag M, Tárnok A, Gerstner AOH,. Concepts for absolute immunophenosubtyping by slide-based cytometry. Transfus Med Hemother 2007; 34: 188-194. (Pubitemid 46883384)
28. Mittag A, Lenz D, Tarnok A,. Quality control and standardization. In:, Sack U, Tarnok A, Rothe G, editors. Cellular diagnostics: Basic principles, methods and clinical applications of flow cytometry. Basel: Karger Verlag; 2008. pp 159-177 (ISBN: 9783805585552).
29. Mittag A, Tárnok A,. Basics of standardization and calibration in cytometry-A review J Biophotonics 2009; 2: 470-481.
30. Tárnok A, Hambsch J, Emmrich F, Sack U, van Son J, Bellinghausen W, Borte M, Schneider P,. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 1999; 20: 113-125. (Pubitemid 29108834)
31. Osmancik P, Hambsch J, Schneider P, Bellinghausen W, Tarnok A,. Soluble endothelial adhesion molecules during paediatric cardiovascular surgery with or without cardiopulmonary bypass. Cardiol Young 2002; 12: 130-137. (Pubitemid 41268505)
32. Butler J, Rocker GM, Westaby S,. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-559. (Pubitemid 23060844)
33. Tárnok A, Schneider P,. Pediatric cardiac surgery with cardiopulmonary bypass: Pathways contributing to transient systemic immune suppression. Shock 2001; 1 (Suppl 16): 24-32.
34. Diegeler A, Tárnok A, Rauch T, Haberer D, Falk V, Battellini R, Autschbach R, Hambsch J, Schneider P, Mohr FW,. Changes of leukocyte subsets in coronary artery bypass surgery: Cardiopulmonary bypass versus "off-pump" techniques. Thorac Cardiovasc Surg 1998; 46: 327-332. (Pubitemid 29035860)
35. Gessler P, Hohl V, Carrel T, Pfenninger J, Schmid ER, Baenziger O, Pre'tre R,. Administration of steroids in pediatric cardiac surgery: impact on clinical outcome and systemic inflammatory response. Pediatr Cardiol 2005; 26: 595-600. (Pubitemid 43015794)
36. Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP,. Dexamethasone reduces the inflammatory response to cardiopulomonary bypass in children. Ann Thorac Surg 2000; 69: 1490-1495. (Pubitemid 30434881)
37. Lindberg L, Forsell C, Jögi P, Olsson A-K,. Effects of dexamethasone on clinical course. C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br J Anaesth 2003; 90: 728-732. (Pubitemid 36700774)
38. Gormley SMC, Armstrong MA, McMurray TJ, McBride WT,. The effect of methylprednisolone on cytokine concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Cytokine 2003; 22: 149-155. (Pubitemid 36808761)
39. Grosek S, Primozic J, Ihan A, Wraber B, Gabrijelcic T, Kosin M,. Interleukin-10. T-lymphocytes, and cardiac output in children after ventricular septal defect repair: A pilot study. Intensive Care Med 2006; 32: 780-784.
40. Grosek S, Ihan A, Wraber B, Gabrijelcic T, Kosin M, Osredkar J, Gmeiner G, Grabnar I, Primozic J,. Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair. Clin Chem Lab Med 2007; 45: 1366-1372. (Pubitemid 47557070)
41. Habermehl P, Knuf M, Kampmann C, Mannhardt W, Schranz D, Kuroczynski W, Wippermann CF, Zepp F,. Changes in lymphocyte subsets after cardiac surgery in children. Eur J Pediatr 2003; 162: 15-21. (Pubitemid 35478204)
42. Braun CM, Huang SK, Bashian GG, Kagey-Sobotka A, Lichtenstein LM, Essayan DM,. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 1997; 100: 400-407. (Pubitemid 27402784)
43. Mayumi H, Zhang Q, Nakashima A, Masuda M, Kohno H, Kawachi Y, Yasui H,. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 1997; 63: 129-137. (Pubitemid 27039048)
44. Sack U, Gerling F, Tarnok A,. Age-related lymphocyte subset changes in the peripheral blood of healthy children-A meta-study. Transfus Med Hemother 2007; 34: 176-181. (Pubitemid 46883382)
45. Huenecke S, Behl M, Fadler C, Zimmermann SY, Bochennek K, Tramsen L, Esser R, Klarmann D, Kamper M, Sattler A, von Laer D, Klingebiel T, Lehrnbecher T, Koehl U,. Age-matched lymphocyte subpopulation reference values in childhood and adolescence: Application of exponential regression analysis. Eur J Haematol 2008; 80: 532-539. (Pubitemid 351677456)
46. Liakopoulos OJ, Schmitto JD, Kazmaier S, Bräuer A, Quintel M, Schoendube FA, Dörge H,. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 2007; 84: 110-118; discussion 118-119.
47. Roth-Isigkeit A, Brechmann J, Dibbelt L, Sievers HH, Raasch W, Schmucker P,. Persistent endocrine stress response in patients undergoing cardiac surgery. J Endocrinol Invest 1998; 21: 12-19. (Pubitemid 28142621)
48. Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, Warot D,. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol 2001; 51: 443-450. (Pubitemid 32852982)
49. Varan B, Tokel K, Mercan S, Dönmez A, Aslamaci S,. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: High dose versus low dose. Pediatr Cardiol 2002; 23: 437-441. (Pubitemid 36927867)
50. Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP,. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 2003; 107: 2823-2828. (Pubitemid 36705993)
51. Bourbon A, Vionnet M, Leprince P, Vaissier E, Copeland J, McDonagh P, Debré P, Gandjbakhch I,. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg 2004; 26: 932-938. (Pubitemid 39433875)
52. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA,. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 10: 317: 653-658. (Pubitemid 17138189)
53. Robertson-Malt S, Afrane B, El Barbary M,. Prophylactic steroids for pediatric open heart surgery. Cochrane Database Syst Rev 2007; 4: CD005550.
54. Warren OJ, Watret AL, de Wit KL, Alexiou C, Vincent C, Darzi AW, Athanasiou T,. The inflammatory response to cardiopulmonary bypass: Part 2-Antiinflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 2009; 23: 384-393.
55. Lugli E, Roederer M, Cossarizza A,. Data analysis in flow cytometry: The future just started. Cytometry A 2010; 77A: 705-713.
56. Steinbrich-Zöllner M, Grün JR, Kaiser T, Biesen R, Raba K, Wu P, Thiel A, Rudwaleit M, Sieper J, Burmester GR, Radbruch A, Grützkau A,. From transcriptome to cytome: integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases. Cytometry A 2008; 73A: 333-340. (Pubitemid 351522116)
57. Johnsen HE, Bøgsted M, Klausen TW, Gimsing P, Schmitz A, Kjærsgaard E, Damgaard T, Voss P, Knudsen LM, Mylin AK, Nielsen JL, Björkstrand B, Gruber A, Lenhoff S, Remes K, Dahl IM, Fogd K, Dybkær K,; on behalf of the Nordic Myeloma Study Group (NMSG) and the Myeloma Stem Cell Network (MSCNET). Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma. Cytometry B Clin Cytom 2010; 78B: 338-347.
58. Pedreira CE, Costa ES, Barrena S, Lecrevisse Q, Almeida J, van Dongen JJ, Orfao A,; EuroFlow Consortium. Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry A 2008; 73A: 834-846.